Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1437552

registered interest
date	02/03/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to prepare for the implementation of the UK NSC’s recommendation on lung cancer screening.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	133255
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>The UK National Screening Committee (UK NSC) plans to open a three-month public consultation on the evidence for lung cancer screening in the week commencing 7 March 2022. The Department will receive the UK NSC’s recommendation on lung cancer screening in individuals at an increased risk following its meeting in June 2022.</p><p>If recommended, NHS England and NHS Improvement will be responsible for implementing the programme in England and preparatory work is underway.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 07/03/2022 11:40:55 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1436509

registered interest
date	28/02/2022
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Social Security Benefits: Uprating
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what assessment she has made of the potential effect of not uprating benefits in line with inflation on levels of child poverty in Gower.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	131290
answer	answer is ministerial correction date of answer 03/03/2022 answer text <p>No such assessment has been made. The Government is up-rating benefits in line with inflation. The Secretary of State undertakes an annual review of benefits and pensions with reference to the Consumer Prices Index (CPI). All benefit up-rating since April 1987 has been based on the increase in the relevant price inflation index in the 12 months to the previous September. The relevant benefits are increasing by 3.1% from April.</p><p> </p><p>The latest statistics on the number and proportion of children who are in low income families by local area, covering the six years, 2014/15 to 2019/20, can be found in the annual publication: <a href="https://www.gov.uk/government/statistics/children-in-low-income-families-local-area-statistics-2014-to-2020" target="_blank">Children in low income families: local area statistics 2014 to 2020 - GOV.UK (www.gov.uk)(opens in a new tab)</a>.</p><p> </p><p>This Government is committed to reducing poverty and supporting low-income families, and believes work is the best route out of poverty. Our approach is based on clear evidence about the importance of parental employment – particularly where it is full-time – in substantially reducing the risks of child poverty and in improving long-term outcomes for families and children.</p> answering member constituency Macclesfield answering member printed David Rutley grouped question UIN 131216 question first answered 03/03/2022 12:12:05 answering member 4033 label Biography information for David Rutley
tabling member	4623 label Biography information for Tonia Antoniazzi

1434765

registered interest
date	23/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his timeline is for approval of the national lung cancer screening programme following its suspension in March 2020 due to the covid-19 outbreak.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	128399
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>All Targeted Lung Health Check (TLHC) sites were operational by September 2020 and are issuing in excess of 30,000 invitations each month, compared to 1,555 each month prior to the pandemic. In 2022/23, the number of operational THLCs sites will increase from 23 to 43, funded by up to £70 million from the NHS Cancer Programme. The UK National Screening Committee is currently considering whether TLHCs should be recommended as a national screening programme.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 128400 133256 question first answered 07/03/2022 15:58:08 answering member 4492 label Biography information for Maria Caulfield previous answer version 53980 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434203

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Education England: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what budget his Department has allocated to Health Education England for workforce growth and medical education in the financial year 2022-23.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127510
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Health Education England’s (HEE) budget for 2022/23 will be announced prior to 1 April 2022.</p><p>Spending plans for individual budgets, including for HEE’s budgets for workforce growth and medical education from 2022/23 to 2024/25, will be subject to a detailed financial planning exercise and finalised in due course.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 25/02/2022 14:53:38 answering member 4362 label Biography information for Edward Argar
tabling member	4623 label Biography information for Tonia Antoniazzi

1434207

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's response to the Health and Social Care Select Committee’s report on Drugs Policy: Medicinal Cannabis, published in September 2019, what steps his Department has taken with the National Institute for Health Research to develop alternative research approaches to support children who are currently receiving cannabis-based products for medicinal use rather than randomised control trials, as set out in that response.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127511
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Research funding can be accessed through applications to the National Institute for Health Research (NIHR). The NIHR relies on researchers submitting high-quality applications and welcomes research proposals to evaluate the safety and clinical efficacy of cannabis-based products for medicinal use. The NIHR and the Medicines and Healthcare products Regulatory Agency (MHRA) will consider novel trial designs and it is not a specific requirement to conduct double blind trials. The MHRA has recently published guidance on the use of real-world data in clinical studies to support regulatory decisions.</p><p>The NIHR and the National Health Service will be supporting two randomised controlled trials into epilepsy. Alternative research approaches, such as an observational study, were considered in the trial design but discounted as it would not produce robust results nor add to the current evidence base.</p><p>In 2018, NHS England asked the British Paediatric Neurology Association (BPNA) to develop interim guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The National Institute for Health and Care Excellence (NICE) then published guidelines covering prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy. The BPNA has subsequently updated their guidance. As with all decisions to prescribe medicines, the General Medical Council expects doctors to use their professional judgement when deciding to what extent any clinical guidance is relevant.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 127512 127513 question first answered 25/02/2022 14:51:45 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434209

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government response to the Health and Social Care Select Committee’s report on Medicinal Cannabis in September 2019, what plans he has to ensure that the role of guidance from the BPNA relating to medical cannabis is replaced by the recently published guidance by NICE.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127512
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Research funding can be accessed through applications to the National Institute for Health Research (NIHR). The NIHR relies on researchers submitting high-quality applications and welcomes research proposals to evaluate the safety and clinical efficacy of cannabis-based products for medicinal use. The NIHR and the Medicines and Healthcare products Regulatory Agency (MHRA) will consider novel trial designs and it is not a specific requirement to conduct double blind trials. The MHRA has recently published guidance on the use of real-world data in clinical studies to support regulatory decisions.</p><p>The NIHR and the National Health Service will be supporting two randomised controlled trials into epilepsy. Alternative research approaches, such as an observational study, were considered in the trial design but discounted as it would not produce robust results nor add to the current evidence base.</p><p>In 2018, NHS England asked the British Paediatric Neurology Association (BPNA) to develop interim guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The National Institute for Health and Care Excellence (NICE) then published guidelines covering prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy. The BPNA has subsequently updated their guidance. As with all decisions to prescribe medicines, the General Medical Council expects doctors to use their professional judgement when deciding to what extent any clinical guidance is relevant.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 127511 127513 question first answered 25/02/2022 14:51:45 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434210

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Cannabis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Process Review of 8 August 2019 and the MHRA guidance issued in December 2021, if the Government will fund an alternative study into the potential merits of medical cannabis for children suffering from severe intractable epilepsy.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127513
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Research funding can be accessed through applications to the National Institute for Health Research (NIHR). The NIHR relies on researchers submitting high-quality applications and welcomes research proposals to evaluate the safety and clinical efficacy of cannabis-based products for medicinal use. The NIHR and the Medicines and Healthcare products Regulatory Agency (MHRA) will consider novel trial designs and it is not a specific requirement to conduct double blind trials. The MHRA has recently published guidance on the use of real-world data in clinical studies to support regulatory decisions.</p><p>The NIHR and the National Health Service will be supporting two randomised controlled trials into epilepsy. Alternative research approaches, such as an observational study, were considered in the trial design but discounted as it would not produce robust results nor add to the current evidence base.</p><p>In 2018, NHS England asked the British Paediatric Neurology Association (BPNA) to develop interim guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The National Institute for Health and Care Excellence (NICE) then published guidelines covering prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy. The BPNA has subsequently updated their guidance. As with all decisions to prescribe medicines, the General Medical Council expects doctors to use their professional judgement when deciding to what extent any clinical guidance is relevant.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 127511 127512 question first answered 25/02/2022 14:51:45 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1422054

registered interest
date	10/02/2022
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Public Expenditure: Northern Ireland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, how much each department in the Northern Ireland Executive has returned to the Treasury since 2016; and what discussions he has had with (a) the Chancellor of the Exchequer and (b) ministers in the Northern Ireland Executive on that matter.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	122784
answer	answer is ministerial correction date of answer 21/02/2022 answer text <p>Any returns by the Northern Ireland Executive to the Treasury are undertaken at Block Grant level not by individual departments. Since 2016, the Executive’s underspends have been largely in two areas: ring-fenced Resource DEL and Financial Transactions Capital.</p><p> </p><p>Budget exchange is a mechanism that allows the Executive to carry forward a forecast DEL underspend from one year to the next, within previously agreed limits and with the consent of Treasury Ministers. Since 2016, the total amount of underspend for each year which cannot be accessed via Budget Exchange for the following year is:</p><p> </p><p><strong>2016/17: </strong>£130.9m<strong> </strong></p><p><strong>2017/18: </strong>£210.1m<strong> </strong></p><p><strong>2018/19: </strong>£254.9m<strong> </strong></p><p><strong>2019/20: </strong>£207m<strong> </strong></p><p><strong>2020/21: </strong>£426.7m</p><p> </p><p>The amount unused in 2020/21 includes £373.3m that had been earmarked for student loan impairments, which did not materialise.</p><p> </p><p>The Secretary of State for Northern Ireland engages with the Chancellor and Treasury Ministers on a regular basis in relation to Northern Ireland’s public finances and wider economy, as well as with the First Minister and deputy First Minister. The Executive’s finances are also reported on by the independent Fiscal Council.</p><p> </p><p> </p> answering member constituency Bournemouth West answering member printed Conor Burns question first answered 21/02/2022 10:37:33 answering member 3922 label Biography information for Sir Conor Burns
tabling member	4623 label Biography information for Tonia Antoniazzi

1416385

registered interest
date	25/01/2022
answering body	Foreign, Commonwealth and Development Office
answering dept id	208
answering dept short name	Foreign, Commonwealth and Development Office
answering dept sort name	Foreign, Commonwealth and Development Office
hansard heading	Sri Lanka: Tamils
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, with reference to the report by the International Truth and Justice Project, entitled Sri Lanka: Torture and Sexual Violence by Security Forces 2020-21, published in September 2021, what steps her Department is taking to support the Tamil population of Sri Lanka; and what steps her Department is taking in response to the recommendations for UN member states in that report.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	111682
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>The UK Government takes very seriously the allegations of torture and sexual violence in the report 'Sri Lanka: Torture and Sexual Violence by Security Forces 2020-2021'.</p><p>The Minister for South Asia, Lord (Tariq) Ahmad of Wimbledon, has raised the importance of these issues on several occasions with the Sri Lankan High Commissioner and the Sri Lankan Foreign Minister G.L. Peiris. During his visit to Sri Lanka of 18-20 January, he raised serious concerns around the deteriorating human rights situation when he met the President, Foreign Minister, and other members of the Sri Lankan Government. The Foreign Secretary raised the importance of upholding human rights when she met Foreign Minister Peiris on 26 October 2021.</p><p>We will continue to support the monitoring of the human rights situation and accountability in Sri Lanka by the Office of the High Commissioner for Human Rights (OHCHR) as mandated by the UN Human Rights Council resolution 46/1 on promoting reconciliation, accountability and human rights in Sri Lanka.</p> answering member constituency Cannock Chase answering member printed Amanda Milling question first answered 02/02/2022 18:00:27 answering member 4454 label Biography information for Dame Amanda Milling
tabling member	4623 label Biography information for Tonia Antoniazzi

1404323

registered interest
date	19/01/2022
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Prisoners: Transgender People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, how many biologically male transgender prisoners housed in the male estate have been subjected to assault and to sexual assault in each of the last five years.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	107674
answer	answer is ministerial correction date of answer 24/01/2022 answer text <p>These figures have been drawn from the HMPPS Incident Reporting System, which records the legal gender of prisoners. They are based on snapshot data collections from March 2018, 2019 and 2021. There was no collection in March 2020 due to the COVID-19 pandemic. Data is not available for 2017. This is because legal gender did not form part of the central data collection in that year.</p><p>In 2017-18 there were 38 assaults and 14 sexual assaults on legally male transgender prisoners in the men’s prison estate. In 2018-19 there were 16 assaults and fewer than 5 sexual assaults. In 2020-21 there were fewer than 5 assaults and fewer than 5 sexual assaults.</p><p>In 2017-18 there were 332 self-harm incidents involving legally male transgender prisoners in the men’s prison estate. In 2018-19 there were 159. In 2020-21 there were 228. Data on attempted suicide is not available.</p><p>We have trained more than 25,000 staff in suicide and self-harm prevention as part of our drive to tackle these issues, and we continue to develop initiatives to better support people in custody.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins grouped question UIN 107675 question first answered 24/01/2022 17:43:11 answering member 4399 label Biography information for Victoria Atkins
tabling member	4623 label Biography information for Tonia Antoniazzi